145 related articles for article (PubMed ID: 3163828)
1. Effects of felodipine in patients with refractory hypertension and progressive renal disease.
Herlitz H; Nyberg G; Granérus G; Björck S; Aurell M
Scand J Urol Nephrol Suppl; 1988; 108():31-4. PubMed ID: 3163828
[No Abstract] [Full Text] [Related]
2. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers: effects on progressive renal disease.
Zucchelli P; Zuccalà A; Gaggi R
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
[No Abstract] [Full Text] [Related]
4. Calcium antagonism with felodipine in essential hypertension. Effects on cardiovascular and renal function, the sympathetic and the renin-angiotensin-aldosterone systems, glucose tolerance and glucoregulatory hormones.
Katzman PL
Acta Med Scand Suppl; 1987; 720():1-62. PubMed ID: 3328471
[No Abstract] [Full Text] [Related]
5. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
Linas S
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of felodipine in patients with reduced renal function.
Herlitz H
Kidney Int Suppl; 1992 May; 36():S110-3. PubMed ID: 1614060
[TBL] [Abstract][Full Text] [Related]
7. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.
Jackson B; Johnston CI
J Hypertens; 1988 Jun; 6(6):495-501. PubMed ID: 2842393
[TBL] [Abstract][Full Text] [Related]
8. [ACE inhibitors and the kidney].
Hörl WH
Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
[TBL] [Abstract][Full Text] [Related]
9. Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.
Amann K; Törnig J; Nichols C; Zeier M; Mall G; Ritz E
Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():33-8. PubMed ID: 8643206
[No Abstract] [Full Text] [Related]
10. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U; Mayer G
Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
Zucchelli P; Zuccalà A; Gaggi R
Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
[No Abstract] [Full Text] [Related]
12. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
13. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
[TBL] [Abstract][Full Text] [Related]
14. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure.
Ruilope LM; Guerrero L; Casal MC; Alcazar JM; Campo C; Mazuecos A; Fernandez ML; Rodicio JL
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S71-3. PubMed ID: 1723462
[TBL] [Abstract][Full Text] [Related]
16. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive treatment and CHD in the elderly.
Fink KS; Ellsworth A
Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
[No Abstract] [Full Text] [Related]
18. [Hypertension--special reference to kidney diseases].
Hayashi M
Nihon Jinzo Gakkai Shi; 2002; 44(5):432-8. PubMed ID: 12216475
[No Abstract] [Full Text] [Related]
19. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
